Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03023124
Title Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor (STRADA)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Italian Sarcoma Group
Indications

solitary fibrous tumor/hemangiopericytoma

Therapies

Trabectedin

Dacarbazine + Doxorubicin

Age Groups: senior | adult
Covered Countries ITA

Facility Status City State Zip Country Details
Nuovo Ospedale di Prato Recruiting Prato Firenze 59100 Italy Details
Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milano MI 20133 Italy Details
Policlinico Universitario Campus Biomedico Recruiting Roma RM 00128 Italy Details
IRCCS Istituto ortopedico Rizzoli Recruiting Bologna 40136 Italy Details
Fondazione Del Piemonte Per L'Oncologia Ircc Di Candiolo - Recruiting Candiolo 10060 Italy Details
Ospedale Giaccone Not yet recruiting Palermo Italy Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field